#' Carbotax study of ovarian tumor growth
#'
#' @description
#'
#' The data presented here come from a study of gene expression changes in
#' ovarian cancer. The current standard treatment for ovarian cancer consists
#' of surgery, followed by either carboplatin and paclitaxel or carboplatin
#' alone. This approach, however, is not effective for all patients. The goal
#' of this study was to identify genes and pathways associated with drug
#' response. To identify such genes, the investigators implanted ovarian cell
#' lines into adult mice and allowed the tumors to grow for 2 months, at which
#' point one of three treatments (carboplatin, carboplatin + paclitaxel, or
#' control) was administered to each mouse. At various time points ranging from
#' 0 to 14 days following the initiation of treatment, the mice were sacrificed,
#' at which point the investigators measured the size of the tumor as well as
#' gene expression in the cancerous tissue.
#'
#' Our analysis here concentrates on relative tumor volume (RTV) as the outcome
#' variable.
#'
#' For this study, there were 34,694 features with expression data and a sample
#' size of 101 mice.
#'
#' @format
#'
#' * `y`: Relative tumor volume. Measurements are on the log2 scale so that y=1
#' means that the tumor has doubled in size since baseline. By definition,
#' y=0 for all samples taken at day 0.
#'
#' * `X`: #' A matrix with 101 rows and 34694 columns of gene expression
#' measurements
#'
#' * `sData`: Data frame containing additional information about the
#' experimental conditions for each sample.
#'
#' * `Treatment`: Treatment received (Carbo, CarboTax, Control)
#' * `Day`: Days since beginning of treatment
#'
#' ### Annotation
#'
#' * Rows of X and elements of y are given matching, arbitrary labels.
#' * Columns of X are labeled with the Gene Symbol.
#' * In addition, a data frame `fData` is provided that contains additional annotation information for each feature.
#'
#' @source
#'
#' Koussounadis A, Langdon SP, Harrison DJ and Smith VA (2014). Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer. *British Journal of Cancer*, **110**: 2975-2984.
#'
#' @name Koussounadis2014
NULL
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.